YK11 is a synthetic steroidal selective androgen receptor modulator (SARM) known for its unique structure and potent anabolic effects. Unlike traditional SARMs, YK11 possesses a steroidal backbone, closely resembling the structure of dihydrotestosterone (DHT), a potent natural androgen. This design allows YK11 to exhibit strong binding affinity to androgen receptors, promoting significant muscle growth and bone density enhancement. Its discovery is relatively recent, and it has gained popularity among bodybuilders and athletes seeking to improve muscle mass and strength without the severe side effects commonly associated with anabolic steroids.
Mechanistically, YK11 functions by binding to androgen receptors in muscle and bone tissue, stimulating anabolic activity. One of its distinguishing features is its ability to upregulate follistatin, a protein that inhibits myostatin, a negative regulator of muscle growth. By inhibiting myostatin, YK11 allows for increased muscle cell proliferation and differentiation, leading to enhanced muscle hypertrophy. This dual action-direct androgen receptor activation and myostatin inhibition-makes YK11 a powerful agent for muscle development. Additionally, it is suggested that YK11 can improve bone health by promoting bone mineral density, making it a potential candidate for treating conditions like osteoporosis.
Despite its promising anabolic properties, YK11's safety and efficacy profile remains under-researched. Most of the current knowledge stems from in vitro studies and anecdotal reports from users. Concerns about its potential side effects, such as liver toxicity and cardiovascular issues, remain unaddressed due to the lack of comprehensive clinical trials.
https://www.hormonerawsource.com/sarm-powders/sarms-powders/yk11-powder-cas-1370003-76-1.html
